Allogene Therapeutics (ALLO) announced that the U.S. Food and Drug Administration, FDA, has cleared its Investigational New Drug, IND, ...

Gameto, a clinical-stage biotech company developing iPSC-based therapies for women’s health, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug ...

The data from the early-stage obesity study of amycretin is a short-term win for Novo Nordisk amid other factors that weigh ...

SEED Therapeutics announced that the U.S. Food and Drug Administration has granted Rare Pediatric Disease and Orphan Drug designations to ...

Atalanta Therapeutics has bagged $97 million, money the biotech plans to use to launch clinical trials for its small ...

Minovacca plans to hire UNL students to work on submitting an Investigational New Drug Application to the U.S. Food and Drug Administration, a request to administer an investigational drug to ...

Kelun-Biotech’s novel ADC drug SKB445 receives NMPA approval to treat advanced solid tumours: Chengdu Sichuan Province, PRC Friday, January 24, 2025, 15:00 Hrs [IST] Sichuan Kel ...

Allogene Therapeutics, Inc. ALLO announced that the FDA has cleared its investigational new drug (IND) application to begin ...

Novo Nordisk stock gains as its subcutaneous investigational candidate, amycretin, achieves superior weight loss compared to ...

With its acceptance by the NMPA, NVK002 is now under regulatory review across three major global markets: the United States, ...

Novo Nordisk's phase 1b/2a clinical trial results revealed that their investigational drug, amycretin, led to an average ...

Wockhardt now intends to file a new drug application (NDA) with the USFDA and seek marketing authorisation application with ...